Search

Scientists are decoding the genetic changes that drive individual cancer cells. This may help them develop more-effective targeted therapies.

… Tuesday, February 27, 2018 Summary Being able to find the genetic mutations that drive individual cells within a tumor may lead to better targeted therapies. Precision oncology is based on the idea that the molecular changes driving cancer can be targeted with drugs to stop a tumor from growing. But

Scientists have uncovered a molecule that, in mice, can promote the regeneration of the thymus, where T cells develop.

… Friday, January 12, 2018 Summary Scientists have identified a molecule that, in mice, can promote the regeneration of the thymus. The finding paves the way toward treatments aimed at repairing this important immune system organ. Love your thymus. This small butterfly-shaped organ in the upper chest is

Research from Sloan Kettering Institute immunologists suggests that the body may mount an immune response to respiratory viruses that lasts longer than previously thought. The discovery could impact the timing of COVID-19 vaccinations.

… Thursday, December 2, 2021 When Sloan Kettering Institute (SKI) postdoctoral fellow William “Teddy” Yewdell embarked on a new research project in 2015, he didn’t know it ultimately could help in fighting a global pandemic. Dr. Yewdell studies how the immune system responds to viruses, including how to

Lisa DeAngelis, MD, Chief Physician Executive and Scott M. and Lisa G. Stuart Chair of Memorial Sloan Kettering Cancer Center (MSK), has been named to amNY Metro and PoliticsNY’s Power Players in Healthcare list.

… Wednesday, November 29, 2023 Lisa DeAngelis, MD, Chief Physician Executive and Scott M. and Lisa G. Stuart Chair of Memorial Sloan Kettering Cancer Center (MSK), has been named to  amNY Metro  and  PoliticsNY ’s Power Players in Healthcare list. The list acknowledges and celebrates healthcare leaders

Memorial Sloan Kettering Cancer Center (MSK) has named William F. Pirl, MD, MPH, as the new Chair of the Psychiatry & Behavioral Sciences Department. Dr. Pirl is a nationally and internationally recognized expert and leader in psycho-oncology. He is no stranger to MSK; he completed his fellowship in psycho-oncology at the institution twenty-five years ago.

… Wednesday, June 25, 2025 Memorial Sloan Kettering Cancer Center (MSK) has named William F. Pirl, MD, MPH, as the new Chair of the  Psychiatry & Behavioral Sciences Department . Dr. Pirl is a nationally and internationally recognized expert and leader in psycho-oncology. He is no stranger to MSK; he completed

Memorial Sloan Kettering Cancer Center President Harold Varmus was awarded the 2008 Henry G. Friesen International Prize in Health Research on September 24 in Toronto.

… Monday, December 1, 2008 Summary Memorial Sloan Kettering Cancer Center President Harold Varmus was awarded the 2008 Henry G. Friesen International Prize in Health Research on September 24 in Toronto. Memorial Sloan Kettering Cancer Center President Harold Varmus was awarded the 2008 Henry G. Friesen

Memorial Sloan Kettering Cancer Center (MSK) recently executed a contract with HealthLinx, a consulting firm that helps hundreds of hospitals achieve Magnet® and Pathway to Excellence ® designation. Under the agreement, MSK’s EBP Consulting Service will provide training in MSK’s proprietary evidence-based practice (EBP) methodology directly to select HealthLinx clients who are looking to improve or enculturate EBP.

… Thursday, August 21, 2025 Memorial Sloan Kettering Cancer Center (MSK) recently executed a contract with HealthLinx, a consulting firm that helps hundreds of hospitals achieve Magnet® and Pathway to Excellence ® designation. Under the agreement, MSK’s EBP Consulting Service will provide training in MSK

When Dave Norkin was diagnosed at 39 with a rare cancer, he was told he had just months to live. Now, a decade later, he’s surviving — thanks to the emerging field of theranostics, which combines imaging and therapy for a search-and-destroy mission.

… Friday, January 1, 2021 Dave Norkin remembers very clearly the first time he met with MSK physician Diane Reidy-Lagunes. It was his daughter’s birthday. She had just turned 3. Then age 39 and an attorney with the US Navy, Dave had come to see Dr. Reidy-Lagunes after being diagnosed with a gastrointestinal

Taking a cue from smartphone technology, scientists are using face-recognition algorithms to improve RNA interference.

… Friday, May 12, 2017 Summary RNA interference (RNAi) is a technique that geneticists use to study the function of genes. A new software program developed by researchers at the Sloan Kettering Institute and their collaborators uses principles derived from face-detection technology to improve the efficacy

Research findings from Memorial Sloan Kettering Cancer Center (MSK) will be featured in this year’s American Association for Cancer Research (AACR) Annual Meeting press program. The AACR is the oldest and largest professional organization dedicated to advancing cancer research, and the press program highlights cancer research that a panel of AACR experts considers the most significant of the year and deserving of media attention.

… Sunday, April 2, 2017 David Hyman, MD, speaks to a patient David Hyman, MD, speaks to a patient. Research findings from Memorial Sloan Kettering Cancer Center (MSK) will be featured in this year’s American Association for Cancer Research (AACR) Annual Meeting press program. The AACR is the oldest and